AzTrials
AzTrials

Genu VarumNCT07798869

Genu Varum, Change of Direction, and Reactive Agility in Youth Football Players

An observational study of Genu Varum, run by Akdeniz University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this observational study is to compare change-of-direction (COD) and reactive agility (RA) performance between football players with and without genu varum and to examine whether lower-limb alignment is associated with these performance measures. The main questions it aims to answer are: 1. Read more about this study

Who is it for?
Ages 13 to 19 years, men onlyHealthy volunteers can take part
Conditions the study is for
Genu Varum
How many people
34 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Mar 2025to 12 Jun 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 19 years
  • Men only
  • Healthy volunteers accepted
  • Child, Adult

Study population: The study population consisted of male youth football players recruited from the academy of a professional football club based in Antalya, Türkiye. The football club competes in the Turkish Süper Lig, the highest tier of professional football in Türkiye.

Who may be able to join

  • At least five years of football experience
  • Participation in football training at least five days per week
  • Voluntary participation in the study

Who cannot join

  • History of lower extremity surgery
  • Current musculoskeletal injury affecting performance

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Akdeniz University

    Antalya

Other trials in Turkey (Türkiye)

About this study

Official title: Does Genu Varum Influence Change of Direction and Reactive Agility Performance in Youth Football Players?

The goal of this observational study is to compare change-of-direction (COD) and reactive agility (RA) performance between football players with and without genu varum and to examine whether lower-limb alignment is associated with these performance measures.

The main questions it aims to answer are:

Read more
  1. Do football players with and without genu varum differ in COD and RA performance?
  2. Is lower-limb alignment associated with COD and RA performance in football players with and without genu varum?

Football players with and without genu varum will undergo assessments of lower-limb alignment, COD performance, and RA performance. The study will compare performance between the two groups and examine the relationship between lower-limb alignment and performance measures.

Conditions
Genu Varum
Keywords
Genu varum, Lower-limb alignment, Football players, Soccer players, Change of direction, Knee alignment, Lower extremity alignment
Medical subject headings
Genu Varum

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07798869
Study groupRoleWhat they receive
Genu Varum GroupFootball players with genu varum who will be assessed for lower-limb alignment, change-of-direction performance, and reactive agility performance.
Control GroupFootball players without genu varum who will be assessed for lower-limb alignment, change-of-direction performance, and reactive agility performance.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change-of-direction performance

    Change-of-direction performance will be assessed using the SpeedCourt system (Globalspeed GmbH, Hemsbach, Germany). The test consists of a 14.5-m running course with four changes of direction. Performance will be evaluated based on total completion time, with lower times indicating better change-of-direction performance.

    Measured: at basline

  2. Reactive agility performance

    Reactive agility performance will be assessed using the SpeedCourt system (Globalspeed GmbH, Hemsbach, Germany). Participants will respond as quickly and accurately as possible to randomly presented visual stimuli and perform the required directional movements. Performance will be evaluated based on total completion time, with lower times indicating better reactive agility performance.

    Measured: at basline

Secondary outcomes (1)
  1. Intercondylar distance and intermalleolar distance

    Lower-limb alignment will be assessed by measuring intercondylar distance (ICD) and intermalleolar distance (IMD) in centimeters. ICD will be measured as the distance between the medial femoral condyles, and IMD as the distance between the medial malleoli, using a standardized measurement procedure.

    Measured: at basline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Sep 2026
  2. Study start1 Mar 2025
  3. Primary completion1 Jun 2025
  4. Study completion12 Jun 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07798869
Sponsor's protocol ID
2025-89
Status last verified
Aug 2026
First submitted
28 Aug 2026
Last updated
3 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Genu Varum, run by Akdeniz University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change-of-direction performance (time frame: at basline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in